Linear accelerators, also known as linacs, are medical devices that use high energy X-rays or electrons to destroy cancer cells and treat tumors. Linear accelerators has become an essential tool in the field of radiation oncology as it helps deliver effective radiation dose for cancer treatment with improved accuracy. The global linear accelerators market is estimated to be valued at US$ 5 Billion in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market key Trends:

Higher demand for cancer treatment has been a key trend propelling growth of the linear accelerators market. According to the World Health Organization (WHO), cancer burden has risen to 18.1 million new cases and 9.6 million cancer deaths in 2018. The increasing prevalence of cancer worldwide has fueled installation of new linear accelerators in hospitals and cancer treatment centers. Moreover, technological advancements in linear accelerators such as image-guided radiation therapy and volumetric modulated arc therapy has improved treatment outcomes for complex cancer cases. This has increased acceptance of linear accelerators for advanced radiation oncology procedures.

SWOT Analysis

Strength: Linear accelerators provide non-invasive treatment for cancer and are more effective than conventional X-ray therapy. They also allow to focus radiation dose accurately on tumor areas.

Weakness: High installation and maintenance costs of linear accelerators limit their widespread adoption. They also require specialized infrastructure and experienced medical professionals to operate.

Opportunity: Growing geriatric population and rising cancer prevalence are increasing the demand for advanced cancer treatment options. Rise in healthcare expenditure in emerging nations also offers new market opportunities.

Threats: Stringent regulatory norms and long product approval times threaten the entry of new players. Economic slowdowns can negatively impact upgrade/replacement purchasing by existing users.

Key Takeaways

The global Linear Accelerators For Radiation Market Growth is expected to witness high growth.

Regional analysis comprises North America dominates the market currently due to presence of major players and rising cancer incidence. Asia Pacific is forecast to grow at fastest pace due to improving access to advanced therapies in countries like China and India.

Key players operating in the market are Varian Medical Systems, Elekta AB, Accuray Incorporated, and Shinva Medical Instrument Co. Ltd. Varian offers a wide range of linear accelerators used for External Beam Radiation Therapy (EBRT) and Stereotactic Radiosurgery (SRS). Elekta provides linear accelerators integrated with advanced imaging and treatment delivery solutions.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it